$211 Million is the total value of ArchPoint Investors's 56 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VBIV | Exit | VBI VACCINES INC CDA | $0 | – | -65,000 | -100.0% | -0.02% | – |
| LABP | Exit | LANDOS BIOPHARMA INC | $0 | – | -127,262 | -100.0% | -0.03% | – |
| ZY | Exit | ZYMERGEN INC | $0 | – | -34,000 | -100.0% | -0.04% | – |
| Exit | ASTRIA THERAPEUTICS INC | $0 | – | -24,331 | -100.0% | -0.09% | – | |
| GOOG | Exit | ALPHABET INCcap stk cl c | $0 | – | -3,100 | -100.0% | -0.12% | – |
| MMM | Exit | 3M CO | $0 | – | -3,000 | -100.0% | -0.14% | – |
| BTI | Exit | BRITISH AMERN TOB PLCsponsored adr | $0 | – | -18,686 | -100.0% | -0.28% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -92,500 | -100.0% | -0.36% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -168,725 | -100.0% | -4.69% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LA Z BOY INC | 42 | Q3 2023 | 24.1% |
| Thermo Fisher SCNTFC | 42 | Q3 2023 | 4.3% |
| Genuine Parts Co Com | 42 | Q3 2023 | 4.4% |
| Dorchester Minerals Lp Com Uni | 42 | Q3 2023 | 7.7% |
| CURTISS WRIGHT CORP | 42 | Q3 2023 | 3.2% |
| Activision Blizzard Inc Put Op | 42 | Q3 2023 | 3.4% |
| APPLE INC. | 42 | Q3 2023 | 3.8% |
| Cisco Systems Inc | 42 | Q3 2023 | 2.7% |
| Exxon Mobil Corporation | 42 | Q3 2023 | 0.5% |
| Enterprise Products Partners L | 41 | Q3 2023 | 1.9% |
View ArchPoint Investors's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View ArchPoint Investors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.